429 results on '"Wu, Y.-L."'
Search Results
2. Prevalence and trend of gonorrhea in female sex workers and men having sex with men in China: a systematic review and meta-analysis
3. Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC
4. Bio-synthesis of molecularly imprinted membrane with photo-regeneration availability for selective separation applications
5. Toward the prevention of coronavirus infection: what role can polymers play?
6. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
7. Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
8. The prevalence and influencing factors for child neglect in a rural area of Anhui province: a 2-year follow-up study
9. Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
10. Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial
11. EFFICIENT UAV FLIGHT PLANNING FOR LOD2 CITY MODEL IMPROVEMENT.
12. Differences in physiological characteristics between two wheat cultivars exposed to field water deficit conditions
13. Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study
14. Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy
15. PHGDH promotes the proliferation and differentiation of primary chicken myoblasts.
16. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study†
17. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
18. A Salmonella Infection Complicated With Suppurative Thyroiditis and Ruptured Aortic Mycotic Aneurysm in a Renal Transplant Recipient
19. Rapid screening of Musa species for resistance to Fusarium wilt in an in vitro bioassay
20. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells
21. Synthesis and crystal structure of complex [Mn(Imdc)2(H2O)2] · 2H2O and its interaction with DNA
22. Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus
23. Hypoxia-inducible factor-1α-induced differentiation of myeloid leukemic cells is its transcriptional activity independent
24. Supplement to: Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
25. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cδ
26. Large strong phases and CP violation in the annihilation processes B̄0→K+K-, K*±K∓, K*+K*-
27. Cavitation resonance: The phenomenon and unknown
28. Toxic Effects of Aminophenols on Aquatic Life Using the Zebrafish Embryo Test and the Comet Assay
29. CP asymmetry in $B \rightarrow \phi K_{S}$ in a general two-Higgs-doublet model with fourth-generation quarks
30. A meshfree formulation of local radial point interpolation method (LRPIM) for incompressible flow simulation
31. Lepton flavor-changing scalar interactions and g-2 of the muon
32. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
33. Reply to ‘Concern on quality-of-life analysis in the OPTIMAL study’ by Couraud et al
34. Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
35. Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)†
36. Development of RBF-DQ method for derivative approximation and its application to simulate natural convection in concentric annuli
37. The HLA-B gene and Hashimoto disease in Han Chinese children: a case-control and family-based study
38. The HLA-DRB1 gene and Graves disease in Taiwanese children: a case-control and family-based study
39. Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma
40. Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy
41. Nearly degenerate mass and bimaximal mixing of neutrinos in the SO(3) gauge model of leptons
42. Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts
43. On-site in situ high-pressure ultrafast pump–probe spectroscopy instrument.
44. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro
45. Ratio of Wnt3a to BMP4 doses is critical to their synergistic effects on proliferation of differentiating mouse embryonic stem cells
46. Isolation, identification, and synthesis of sex pheromone components of female tea cluster caterpillar,Andraca bipunctata walker (Lepidoptera: Bombycidae) in Taiwan
47. 593P MET TKIs in Asian patients (pts) with MET exon 14 skipping NSCLC: A matching-adjusted indirect comparison (MAIC).
48. LBA1 Efficacy and safety of adjuvant alectinib vs platinum-based chemotherapy (CT) in patients (pts) from Asia with resected, early-stage ALK+ non-small cell lung cancer (NSCLC): A sub analysis of ALINA.
49. EP08.01-02 Single-Cell RNA Sequencing Reveals Unique Immune Landscape in Rare-Mutant Non-Small Cell Lung Cancer Undergoing Chemo-Immunotherapy.
50. EP08.01-01 Subtyping EGFR-mutated NSCLC Patients with Adjuvant TKIs or Chemotherapy Using Deep Radiomic Signatures.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.